Neu Health Joins Cedars-Sinai Accelerator to Revolutionize Parkinson’s Disease and Dementia in the US

Neu Health, a leading digital neurology care platform, is excited to announce its acceptance into the Cedars-Sinai Accelerator program in Los Angeles. This achievement marks a significant milestone for Neu Health as it continues to drive innovation in Parkinson’s Disease and Dementia care. Neu Health was founded based on 10+ years of research at Oxford University and currently serves patients across hospitals in the NHS. John Glaser, Board Chairman of Neu Health said,  “There is a significant need to improve the care of people with Dementia and Parkinson's in the US, conditions affecting over 10 million people including members of my family. The Cedars program is a very important step in Neu Health’s introduction of its technology and services to America.” 

 

The Cedars-Sinai Accelerator, known for fostering groundbreaking advancements in medical technology, will provide Neu Health with unparalleled resources and mentorship to accelerate its growth. This program is designed to support startups that are transforming healthcare through cutting-edge solutions, and Neu Health’s inclusion is a testament to its potential to impact the industry positively.

 

Neu Health is dedicated to enhancing patient care through its state-of-the-art digital health platform, which leverages patient assessments and artificial intelligence to offer personalized and actionable health insights. The solution provides patients with educational resources to ensure symptom management and medication adherence as they go through their care journey while connecting the entire care team. The company's innovative approach improves health outcomes and streamlines the patient experience.

 

“We are honored and excited to join the Cedars-Sinai Accelerator program,” said Caroline Cake, CEO and Founder of Neu Health. “This opportunity aligns perfectly with our mission to revolutionize neurology care through technology. The support and expertise from Cedars-Sinai will be invaluable as we advance our platform and expand our impact for patients.”

 

For more information about Neu Health and its participation in the Cedars-Sinai Accelerator program, please visit: https://www.cedars-sinai.org/newsroom/cedars-sinai-accelerator-welcomes-10th-class-of-health-tech-startups/

Previous
Previous

Neu Health, ESNEFT & Health Innovation East Shortlisted for the 2024 HSJ Awards, Setting a New Standard for Healthcare Excellence 

Next
Next

Pioneering Parkinson’s Care: The First NHS Outcomes using the Neu Health Platform